Adicet Bio, Inc. (ACET) by event type
ACET moves most on analyst upgrades — a median of -0.10% at 30 minutes across 12 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ACET overview →
How ACET reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,717 of 2,679 | 12 | -0.10% | 50% | -0.98% |
| Rating reiterations 2,335 of 3,515 | 75 | -0.06% | 39% | 0.00% |
Last 3 years, pulled 2026-08-31. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how ACET usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Rating reiterations → · ACET overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CRISPR Therapeutics AG - Common Shares (CRSP) | 291 | +0.10% | 53% |
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
| Xencor, Inc. (XNCR) | 288 | +0.09% | 51% |
| Accuray Incorporated (ARAY) | 286 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.